TrialPanorama/Dataset huggingface dataset:
Please select the outcome measures that correspond to the clinical trial below.
Title: Effect of Labor Dance and Music on Labor Pain and Fear of Childbirth
Brief Summary: The study was conducted to investigate the effect of labor dance and music used during the active phase of labor on labor pain and fear of childbirth. The study was designed as a single-blind randomized controlled intervention trial. The participants included in sample are taken into 3 groups (totally 93 participants). A total of 93 individuals, 31 of whom were in the dance group (D), 30 in the music group (M), and 32 in the control group (C), were included in the survey. Data were collected between 15 February 2018 and 15 June 2018 by means of a Personal Information Form, the Labor Monitoring Form, the Visual Analogue Scale (VAS), and version A of the Wijma Delivery Expectancy Questionnaire (W-DEQA).


Options:
A: Visual Analogue Scale Score, (Baseline)
B: Fear of childbirth (pregnancy 12-24 weeks); Fear of childbirth (pregnancy 32-36 weeks); Fear of childbirth (postpartum 1 week)
C: Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ-A) (Change from the Wijma Delivery Expectancy/Experience Questionnaire Version A scores at pre-education and post-education (4 weeks later).); Childbirth Self-Efficacy Inventory (CBSEI) (Change from the Childbirth Self-efficacy Inventory scores at pre-education and post-education (4 weeks later).); The depression anxiety and stress scale (DASS-21) (Change from the Depression Anxiety and Stress Scale scores at pre- education, post-education (4 weeks later) and postpartum 6-8 weeks.); The Wijma Delivery Expectancy/Experience Questionnaire B version (W-DEQ-B) (Change from The Wijma Delivery Expectancy/Experience Questionnaire B version (W-DEQ-B) scores at postpartum 6-8 weeks.)
D: Change in Fear of labor (childbirth self-efficacy and pain catastrophizing) (Baseline (pre-intervention, 3rd trimester); Post-intervention (prior to birth)); Perceived labor pain (Postpartum (average of 6 weeks post-birth)); Pain medication use during labor (Labor (during childbirth)); Childbirth satisfaction (Postpartum (average of 6 weeks post-birth)); Change in Depression (Baseline (pre-intervention, 3rd trimester); Post-intervention (prior to birth); Postpartum (average of 6 weeks postbirth); Follow-up (1-2 years post-birth))

Answer: A
Please select the outcome measures that correspond to the clinical trial below.
Title: Integrated Psychosocial Group Treatment (IPGT): A Randomized Pilot Trial of a Harm Reduction and Preventative Approach for Patients With Chronic Pain at Risk for Opioid Misuse
Brief Summary: A fundamental challenge for healthcare is to achieve a balance between decreasing the misuse of opioids and associated harms while optimizing patient care, including the provision of multidisciplinary treatments for chronic pain. However, despite recommendations that non-pharmacological interventions are rudimentary in the management of chronic pain, the literature describing which psychosocial interventions are best practice is nearly non-existent. Most of the psychosocial treatments that target either CNCP or opioid misuse are very general and broad-based therapies. However, there is a lack of evidence-informed direction guiding which psychosocial treatments should be adapted to this specialized population and thus, further research is needed.


Options:
A: Mean Number of Alcohol and Drug Use Days Out of Past 30 (30 days previous, assessed at 12-month follow-up)
B: Smoking Abstinence (2 weeks post quit day)
C: Feasibility of attrition (12 Months)
D: Change in pain symptoms (Change from baseline through study completion (9 months post-treatment)); Change in aberrant drug-related behaviors (Change from baseline through study completion (9 months post-treatment))

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses
Brief Summary: This cohort study was initiated to predict the findings of CAROLINA trial in a real world setting using electronic claims data from insurance databases with results anticipated prior to the completion of CAROLINA.


Options:
A: Relative hazard of composite outcome of Stroke, MI, and Mortality (Through study completion (a median of 120-140 days))
B: Relative hazard of composite outcome of Stroke, MI, and Mortality (Through study completion (a median of 118-123 days))
C: Composite Cardiovascular (CV) Outcome (From treatment initiation to end of follow-up, up to 53 months)
D: Relative hazard of composite outcome of Stroke, MI, and Mortality (Through study completion (a median of 154-188 days))

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure
Brief Summary: The occurrence of arterial hypertension (AH) during pregnancy is a major cause of fetal, neonatal and maternal morbidity and mortality in western countries. It is estimated that about 10% of pregnancies are complicated by AH (80 000 women / year in France). It is therefore essential to diagnose AH with certainty in order to set-up appropriate care and follow its evolution.


Options:
A: Gestational age (GA) (Throug study completion, from the first contact with the gynaecologist (after fertilization) untill 34 weeks of gestation.); hospitalization (From 32 weeks of gestation until 34 weeks of gestation); Changes in CV physiological parameters - electrocardiogram (ECT) with Doppler ultrasonography (Month 3 to month 9); changes in CV physiological parameters - impedance cardiography (Month 3 to month 9); changes in CV physiological parameters - bio impedance (Month 3 to month 9); Arterial parameters - pulse transit time (Month 3 to month 9); Arterial parameters - pulsatility index (Month 3 to month 9); Arterial parameters - resistivity index of the left and right arcuate arteries (Month 3 to month 9); venous parameters - venous pulse transit time of the hepatic and left and right renal veins (Month 3 to month 9); venous parameters - hepatic vein impedance index (Month 3 to month 9); venous parameters - left and right renal interlobar vein impedance indices (Month 3 to month 9); systolic blood pressure (Month 3 to month 9); diastolic blood pressure (Month 3 to month 9); Mean arterial blood pressure (Month 3 to month 9); Total body water (Month 3 to month 9); extracellular water (Month 3 to month 9); intracellular water (Month 3 to month 9); ECW/ICW ratio (Month 3 to month 9); stroke volume (Month 3 to month 9); hear rate (beats/min) (Month 3 to month 9); cardiac output (l/min) (Month 3 to month 9); velocity index (1/1,000/s) (Month 3 to month 9); acceleration index (1/100/s²) (Month 3 to month 9); total peripheral resistance (dyn·s·cm-5) (Month 3 to month 9)
B: Comparison of Noninvasive Systolic Blood Pressure Readings to Invasive Blood Pressure Measurement (Single time point measurement (1 day))
C: Primary outcome (composite indicator reflecting activities associated with recognition and management/treatment of pre-eclampsia) (Outcome is evaluated at one month post delivery)
D: Hypertension specific intervention (Through study completion, an average of 9 months)

Answer: D
Please select the outcome measures that correspond to the clinical trial below.
Title: Magnetic Non-Invasive Acupuncture For Infant Comfort A Pilot Study in Preterm Infants Requiring Eye-exam for Retinopathy of Prematurity
Brief Summary: The purpose is to investigate whether non-invasive acupuncture - NIA (i.e. acupuncture without needles) will help reduce pain for babies in the Neonatal Intensive Care Unit (NICU) during their routine weekly eye-exam for Retinopathy of prematurity. Retinopathy of prematurity (ROP) is an eye disease most commonly affecting premature babies born weighing less than 1250 grams. Retinopathy of prematurity occurs because these premature babies require oxygen because of their immature lungs. The oxygen then stimulates the growth of blood vessels in the retina, causing the retina to be detached from the eye, which causes vision impairment.

To examine if the vessels grow at the back of the eye, an eye-doctor visits bi-weekly once the baby is 32 weeks corrected age to assess if the blood vessels change. If there is a lot of growth, the eye-doctor would use a laser to treat the eye to prevent further growth.

During the bi-weekly eye-exam, the premature infant receives sucrose (a type of sugar) for pain management. The investigator will assess pain a premature babies experience during this exam and found that there are extremely high scores of pain despite sucrose and the investigator believe this pain and stress caused by these procedures could be reduced by adding:

Magnetic Acupuncture

Also, untreated pain causes stress (lower oxygen levels, higher heart rates), discomfort and poorer long term outcomes.

Finding the best treatment and prevention for the pain caused by procedures in the NICU is therefore extremely important for any baby.


Options:
A: Hypersensitivity to pain (At 15 month vaccination (Visit 5))
B: Changes in Premature Infant Pain Profile (PIPP) scores (Comparison of baseline (= 1 hour before eye-exam) and after eye-exam (1 hour after))
C: level of COMFORT with videotaped COMFORT behavior scale (first 24 hours postoperative)
D: Cortical oxy-haemoglobin increase (During the procedure)

Answer: B
Please select the outcome measures that correspond to the clinical trial below.
Title: Project LiGHT (Living Green and Healthy for Teens): A Novel Weight Management Program That Emphasizes the Benefits of a Healthy Lifestyle
Brief Summary: This study is the second of three sub-studies aimed at evaluating the outcomes of the Living Green and Healthy for Teens (LiGHT) program, delivered through the Aim2Be app (v2.2). Aim2Be is an app for 10 to 17 year olds and their families that is intended to help them shift from an healthy lifestyle toward better health habits in four areas: nutrition, physical activity, recreational screen time, and sleep. This second evaluation has the following aims to: 1) describe reach; 2) assess change in knowledge of Canadian health recommendations; and 3) assess change in lifestyle behaviours and weight outcomes and whether these changes are moderated by involvement in the app. This study uses a two-group parallel/crossover randomized controlled trial design following N=200 families for six months.


Options:
A: Change in Body Mass Index z-score (youth) (Baseline, 3 months, 6 months); Change in health behaviour knowledge (youth) (Baseline, 3 months, 6 months); Change in objective dietary behaviour (youth) (Baseline, 3 months, 6 months); Change in number of daily steps (youth) (Baseline, 3 months, 6 months); Change in screen behaviour (youth) (Baseline, 3 months, 6 months)
B: Weight reduction (1 year)
C: Percentage of Days App Used Over 12 Weeks (12 weeks); Usability (12 weeks); Acceptability (12 weeks); Burden (12 weeks)
D: Weight Loss (Change from baseline to 18-months.)

Answer: A
Please select the outcome measures that correspond to the clinical trial below.
Title: Leveraging mHealth Messaging to Promote Adherence in Teens With CKD
Brief Summary: The overall goal of this study is to develop and test effectively framed mobile health (mHealth) messages to promote medication adherence in teens with chronic kidney disease (CKD).


Options:
A: Response rate (up to 10 weeks after receiving the questionnaire)
B: Overall response rate (Up to 3 months (from February 3 2017 to maxium Maj 5 2017))
C: Change in Rolland Morris Disability Questionnaire (Change from baseline to 52 weeks)
D: Antihypertensive medication adherence (8 weeks during the study)

Answer: D
Please select the outcome measures that correspond to the clinical trial below.
Title: Effects of Alternate Day Fasting and Exercise on Body Weight, Visceral Fat, and Metabolic Parameters in Overweight or Obese Adults: A Randomized Controlled Trial
Brief Summary: Alternate day fasting is known to be helpful to control weight and have a positive effect on insulin resistance and cardiovascular risk factors. However, there have been no studies on weight reduction program combining alternate day fasting with exercise which preserves lean mass in Korea. The purpose of this randomized clinical trial is to examine the effects of alternate day fasting and exercise on weight reduction, visceral fat, and metabolic parameters in overweight or obese adults.


Options:
A: Body weight (Change from baseline to week 24)
B: Change in body weight (Baseline and weeks 2, 4 and 8)
C: Total fat oxidation in response to eTRF (Week 1 or Week 5); Total fat oxidation in response to mTRF (Week 1 or Week 5); Insulin sensitivity in response to eTRF (Week 1 or Week 5); Insulin sensitivity in response to mTRF (Week 1 or Week 5); Glucose control in response to eTRF (Week 1 or Week 5); Glucose control in response to mTRF (Week 1 or Week 5)
D: Change in body weight (baseline, 8 weeks)

Answer: D
Please select the outcome measures that correspond to the clinical trial below.
Title: Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic Fibrosis: Randomized Controlled Trial
Brief Summary: The purpose of this study is to investigate the effects of aerobic exercise on glucose tolerance in individuals with cystic fibrosis.

The hypothesis is that performing High Intensity Interval Training glucose tolerance will improve in individuals with cystic fibrosis.


Options:
A: Change in forced expiratory volume in 1 second (FEV1) (%predicted) (Baseline to 3 months and Baseline to 6 months); Change in peak oxygen uptake (% predicted) (Baseline to 3 months and Baseline to 6 months); Change in number of steps per day (Baseline to 3 months and Baseline to 6 months)
B: Correlation between number of repetitions (STS Test) and 6-Minute Walking Distance (This outcome will be measured after both tests realization up to 15 minutes.)
C: The six-minute walking distance (0, 1, 2 months)
D: Change in glucose tolerance (Measured at baseline, after 8 and 16 weeks.)

Answer: D
Please select the outcome measures that correspond to the clinical trial below.
Title: Effects of a Long-term Home-based Exercise Training Program Using Minimal Equipment vs Usual Care in COPD Patients: A Multicenter Randomized Controlled Trial
Brief Summary: The aim of this study is to assess the effectiveness of a home-based exercise training program in COPD patients who did not participate in an inpatient or outpatient rehabilitation program within the last 2 years.


Options:
A: Physical activity (Change between baseline (T0) and directly after the intervention, after 4-6 months from baseline (T1)); Physical activity (Change between T1 and T2: 3 months follow up)
B: Dyspnea (Chronic Respiratory Questionnaire (CRQ) domain) (Change from baseline to 12 months)
C: To determine the impact of the intervention initiated after hospital discharge from a COPD exacerbation on the rate of COPD related re-hospitalizations in the intervention versus the control group . (12 months); To determine the impact of the intervention initiated after hospital discharge from a COPD exacerbation on the rate of the composite outcome, COPD related hospitalizations or death in the intervention versus the control group. (12 months)
D: Endurance Time During Endurance Shuttle Walk Test (ESWT) to Symptom Limitation After 8 Weeks (Week 8)

Answer: B
Please select the outcome measures that correspond to the clinical trial below.
Title: Standard vs Long IV Catheter Long-Term IV Survival Comparison
Brief Summary: In patients with difficult IV access, ultrasound-guided catheter insertion is a preferred technique. However, many peripheral catheters fail and must be replaced, adding extra pain and difficulty for the patient, and requiring more healthcare provider time to maintain. In preliminary studies, we determined that catheters which extend further into the vein have a smaller failure rate. This study will compare two lengths of catheters to see if the longer catheters have better survival in a population of patients who have difficult IV access. Patients will be randomized to receive a standard length or extra-long venous catheter, which will be monitored daily for functionality during the patient's hospital course.


Options:
A: Reduction in number of minor surgical procedures that may be required to deliver fluids into the blood of critically ill patients by using the ultrasound guided technique (1 Day)
B: Duration of IV Survival (30 days)
C: Number of Participants with Successful Securing of Peripheral Vein on First Attempt (60 minutes)
D: Overall success rate of IV placement (Up to 30 minutes)

Answer: B
Please select the outcome measures that correspond to the clinical trial below.
Title: A Clinic-randomized Trial of a Clinical Decision Support System to Improve Dental Provider Delivery of Brief Tobacco Interventions and Quitline Referrals
Brief Summary: The overarching goal of this project is to reduce smoking-associated morbidity and mortality by increasing the number of patients who are referred for tobacco cessation counseling. Using a stratified, group-randomized, controlled, 2-arm trial conducted in two settings, the investigators will compare smoking-related clinical decision support (CDS) to usual care.


Options:
A: 7 Day Point Prevalence of Cigarette Abstinence (6-month follow up); 7 Day Point Prevalence of Cigarette Abstinence (Week 8)
B: Self- Reported 7-day Abstinence (6 Months); Carbon Monoxide (CO)-Confirmed 7-day Abstinence (6-Months); Rates of Smoking Cessation Continuous From First Quit Day to 6 Months (6-Months); Self-reported 7-day Abstinence (12 Months); CO-confirmed 7-day Abstinence (12 Months)
C: Percentage of Smokers With Delivery of Brief Interventions and/or Referral to Treatment (within a week of the index dental encounter)
D: Biochemically/pharmacologically-confirmed 12-month continuous abstinence as evidenced by self-reports of nonsmoking status in all interviews (i.e., at 3, 6, and 12 months) (12 months)

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Ultrasound-Guided Vascular Puncture and Catheterization
Brief Summary: To assess and improve the safety and success rate of vascular puncture and catheterization using ultrasound-guided methods.


Options:
A: Success rate of arterial or femoral catheter placement (1 day)
B: Number of Attempts (Immediately during procedure. (up to 30 minutes))
C: Successful rate without extra vascular damage (Through study completion, an average of 1 year.)
D: Incidence of major vascular complications (up to 30 days post-procedure)

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Ultrasound-Guided Vascular Puncture and Catheterization
Brief Summary: To assess and improve the safety and success rate of vascular puncture and catheterization using ultrasound-guided methods.


Options:
A: elevation of thumb capillary lactate after the procedure (30 days)
B: Success rate (at first attempt, as average 5 min)
C: Successful rate without extra vascular damage (Through study completion, an average of 1 year.)
D: First successful central venous catheterization rate (Interval between skin penetration of the needle or angiocatheter and installation of the indwelling catheter, an expected average of 3 minutes)

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Ultrasound-Guided Vascular Puncture and Catheterization
Brief Summary: To assess and improve the safety and success rate of vascular puncture and catheterization using ultrasound-guided methods.


Options:
A: Only one attempt at arterial puncture was necessary (yes/no) (Day 0 - end of procedure)
B: Quick Disabilities of the Arm Shoulder and Hand (DASH) Questionnaire Score (0-100) (1 year); Thumb and Forefinger Pinch Strength Test (1 year); Hand Grip Strength Test (1 month)
C: Successful rate without extra vascular damage (Through study completion, an average of 1 year.)
D: Duration of Use of Arterial Cannula (During Procedure)

Answer: C
Please select the outcome measures that correspond to the clinical trial below.
Title: Pragmatic Trial of User-centered Clinical Decision Support to Implement EMergency Department-initiated BuprenorphinE for Opioid Use Disorder
Brief Summary: Emergency Departments (EDs) frequently care for individuals with Opioid Use Disorder (OUD). Buprenorphine (BUP) is an effective treatment option for patients with OUD that can safely be initiated in the ED. At present, BUP is rarely initiated as a part of routine ED care. Clinical decision support (CDS) represents a potential approach to accelerate adoption of this best practice into routine emergency care. The goal of this trial is to determine whether implementation of a user-centered clinical decision support (CDS) system can increase adoption of initiation of BUP into the routine emergency care of individuals with OUD.


Options:
A: Count of Initiating BUP in the ED With Referral for Ongoing MOUD With User-centered CDS Compared With Usual Care (Upon discharge (Up to 1 day))
B: extent to which a computer-based clinical decision-support system (accompanying computerized provider order-entry) can improve the quality of medication ordering and monitoring (two years)
C: Number of neonatal deaths (18 months)
D: Use of IV fluid (Intervention is 3 months per hospital)

Answer: A
Please select the outcome measures that correspond to the clinical trial below.
Title: A Randomised Controlled Trial to Increase HIV Testing Demand Among Truck Drivers and Sex Workers Through Offering Self-Administered Oral HIV Testing at North Star Alliance Clinics in Kenya
Brief Summary: The study aimed to assess whether advertising the availability of self-administered oral HIV testing kits increases the number of truck drivers and female sex workers who come to the North Star Alliance clinics for HIV testing (Demand creation). The investigators sent text messages to eligible truck drivers and female sex workers registered in the North Star Alliance electronic health record system who, based on those records, were not accessing HIV testing regularly and randomized them to receive one of two messaged, (1) the standard message sent to all clients who have not tested for HIV in the past 3 months reminding them of the availability of HIV testing at North Star clinics or (2) a text message announcing the availability of HIV self-testing kits fat all North Star clinics in Kenya. The investigators then compared the number of truck drivers and female sex workers from our samples who came to the clinic for HIV testing over a 2 month period following the first text message in the two study arms.


Options:
A: Number of Participants Who Report Starting Any Modern Method of Contraception Since the Start of the Study (4-months post-encouragement)
B: Adherence to cervical cancer screening (step1) (Up to 20 months)
C: Linkage to Care - Participants Who Received Cluster of Differentiation 4 (CD4) T-cell Count Test Result Within 3 Months of Testing HIV-positive (Binary) (3 months); Timely Antiretroviral Therapy (ART) Initiation (Participants Eligible for ART Who Initiate Treatment Within 3 Months of Diagnosis) (3 months); Retention in Care - ART Eligible (Participants Eligible for ART Who Initiated ART and Who Remain on Treatment) (12 months); Retention in Care - Non-ART (Participants Who Return for Repeat CD4 Testing Within 12 Months of Diagnosis) (12 months); Adherence to ART - Objective (Viral Load Test Results <400 Copies/mL) (12 months); Adherence to ART - Subjective (Self-reported Ability to Take ART as Prescribed in Last Month) (12 months)
D: The Proportion who tested for HIV over 2 months follow-up (2 months following the first text message)

Answer: D